广康生化：股东拟减持公司不超2.6757%股份

Core Viewpoint - The shareholder, Ruihong Kaiyin No. 1 Equity Investment Fund Partnership (Limited Partnership), plans to reduce its stake in Guangkang Biochemical (300804) by up to 1.98 million shares, representing 2.6757% of the company's total share capital within three months after three trading days [1] Summary by Category - Shareholder Action - The shareholder holds 2.6757% of Guangkang Biochemical and intends to reduce its holdings through centralized bidding and block trading [1] - The planned reduction is capped at 1.98 million shares, which is equivalent to 2.6757% of the total share capital of the company [1]